The study uncovers hippocampal neurons that differentially respond to sugars and fats, suggesting new avenues for combating obesity through targeted therapies.
What Coherus’ $40M sale of its Humira biosimilar says about the crowded market
Coherus BioSciences is selling its Humira biosimilar for just $40 million, only three years after it won FDA approval, showing just how crowded the market
June 28, 2024